Skip to content

Arena pharmaceuticals stock

19.02.2021
Trevillion610

6 Mar 2020 On Thursday, shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) marked $49.20 per share versus a previous… Arena Pharmaceuticals is focused on delivering solutions for cardiovascular, central nervous system, IPO Status Public Stock Symbol NASDAQ:ARNA. Based on 6 Wall Street analysts offering stock ratings for Arena Pharma in the last 3 months (by analysts ranked 0 to 5 stars). All Analysts. Top Analysts  14 Feb 2020 GW&K INVESTMENT MANAGEMENT LLC bought a fresh place in Arena Pharmaceuticals Inc. (NASDAQ:ARNA). The institutional investor  Information about which ETFs are holding the stock ARNA, Arena Pharmaceuticals Inc, from ETF Channel.

ARNA, Arena Pharmaceuticals - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines.

Arena Pharmaceuticals Highlights Strategic Plan Driving Near And Long-term Growth With Eight Ph 2 And Ph 3 Data Readouts In 2020-21 And One New IND Per Year For The Next 5 Years 6 Wall Street analysts have issued 12-month price targets for Arena Pharmaceuticals' stock. Their forecasts range from $51.00 to $83.00. On average, they anticipate Arena Pharmaceuticals' stock price to reach $65.00 in the next twelve months. This suggests a possible upside of 57.6% from the stock's current price. Real-time trade and investing ideas on Arena Pharmaceuticals, Inc. ARNA from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers

Get breaking news and analysis on Arena Pharmaceuticals, Inc. (ARNA) stock, price quote and chart, trading and investing tools.

Detailed price information for Arena Pharmaceuticals (ARNA-Q) from The Globe and Mail including charting and trades. Stock Reports +. Download a  Arena Pharmaceuticals Inc. Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien Find the latest Arena Pharmaceuticals, Inc. (ARNA) stock quote, history, news and other vital information to help you with your stock trading and investing. Arena Pharmaceuticals, Inc. Common Stock (ARNA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Get breaking news and analysis on Arena Pharmaceuticals, Inc. (ARNA) stock, price quote and chart, trading and investing tools. Real time Arena Pharmaceuticals (ARNA) stock price quote, stock graph, news & analysis. ARNA, Arena Pharmaceuticals - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines

Stock quote and company snapshot for ARENA PHARMACEUTICALS INC ( ARNA), including profile, stock chart, recent news and events, analyst opinions, and 

14 Feb 2020 GW&K INVESTMENT MANAGEMENT LLC bought a fresh place in Arena Pharmaceuticals Inc. (NASDAQ:ARNA). The institutional investor  Information about which ETFs are holding the stock ARNA, Arena Pharmaceuticals Inc, from ETF Channel. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has 240 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange  Detailed price information for Arena Pharmaceuticals (ARNA-Q) from The Globe and Mail including charting and trades. Stock Reports +. Download a 

Find the latest Arena Pharmaceuticals, Inc. (ARNA) stock quote, history, news and other vital information to help you with your stock trading and investing.

14 Feb 2020 GW&K INVESTMENT MANAGEMENT LLC bought a fresh place in Arena Pharmaceuticals Inc. (NASDAQ:ARNA). The institutional investor  Information about which ETFs are holding the stock ARNA, Arena Pharmaceuticals Inc, from ETF Channel. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has 240 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange 

beard oil target - Proudly Powered by WordPress
Theme by Grace Themes